Pharma News

Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb

www.coldchainplatform.com, September 19th, 2023

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine

www.coldchainplatform.com, September 12th, 2023

Samsung Biologics appoints new leadership to oversee quality and regulatory affairs

www.coldchainplatform.com, September 7th, 2023

LOTTE BIOLOGICS Holds 'ESG Declaration Ceremony'

www.coldchainplatform.com, September 1st, 2023

Resilience Announces Joint Venture with Lifera to Develop Manufacturing Facility in Saudi Arabia

www.coldchainplatform.com, August 30th, 2023

SK bioscience and Vaxxas Enter Joint Development Agreement

www.coldchainplatform.com, August 28th, 2023

AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project

www.coldchainplatform.com, August 16th, 2023

Astellas to Open New Life Sciences Facility in DivcoWest’s Cambridge Crossing Neighborhood

www.coldchainplatform.com, August 11th, 2023

China Medical Administration Accepts Astellas' Biologics License Application for Zolbetuximab

www.coldchainplatform.com, August 2nd, 2023

Samsung Biologics releases 2023 ESG Report, reaffirming its social responsibility commitments

www.coldchainplatform.com, July 20th, 2023

Follow CCP

Read More